The effects of Quercetin on the management of diabetes mellitus

Not Applicable

• Conditions: Diabetes.; Non-insulin-dependent diabetes mellitus; E10-E14

• Registration Number: IRCT2012101911168N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

age range 35-60 years; having controlled diabetes (no need for changes in oral hypoglycemic medication during the study or having HbA1C <7%, pre-prandial capillary blood glucose <150 mg/dl and peak postprandial capillary blood glucose <180 mg/dl); maximum period of 10 years from the diagnosis of the disease; having normal blood pressure (systolic and diastolic blood pressure: <120 mmHg and <80 mmHg, respectively).
Exclusion criteria: smoking and/or drinking alcohol; having documented liver/kidney and/or lung diseases, kidney stone or any other type of chronic and/or acute inflammatory disorder; taking any lipid lowering and/or hypotensive medication and multi-vitamin mineral supplements; having documented clinically significant secondary complication of the disease (i.e. diabetic retinopathy, nephropathy and neuropathy)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified